Clinical trial for Ischemic Stroke, Acute
Official title Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
ClinicalTrials.gov ID: NCT06352619
What this study is testing
- What it's testing
- The study wants to find the safest and most effective way to lower blood pressure after endovascular clot removal in acute ischemic stroke.
- Who it's for
- Adults who have had clot‑removal surgery for a recent stroke and have a systolic blood pressure of 150 mmHg or higher.
- What's involved
- Participants will be randomly assigned to one of three blood‑pressure plans: minimal lowering, moderate lowering, or intensive lowering. They will receive medication and have their blood pressure checked regularly during the hospital stay.
- Time commitment
- The trial lasts for the hospital stay after the procedure, with several blood‑pressure checks and medication adjustments as needed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years;
- Use of endovascular therapy (EVT) within 24 hours of symptom onset or last known well according to local guidelines;
- Sustained high systolic blood pressure ≥150 mmHg (2 readings \<10 mins apart) within 3 hours after completion of EVT.
You likely can't join if
- 1.Any definite contraindications to BP lowering treatment.
The study team makes the final eligibility decision.
Where it is enrolling
- Sydney, New South Wales, Australia
- Calgary, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sydney, New South Wales, Australia; Calgary, Alberta, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.